Who Can Inject Botox in Georgia? Scope of Practice 2026

Georgia is an easy state to answer this question about badly. The two phrases Georgia med spas repeat most often, "good faith exam" and "office-based cosmetic procedure rule," appear nowhere in Georgia's injectable rules, and the citation usually attached to them points at a chapter about something else.

So this guide works licence by licence, with a direct verdict at the top of each one and the instrument that creates each requirement. Where Georgia has genuinely not answered a question, it says so instead of inventing a rule. For how Georgia compares with the other forty-nine states, see our national who-can-inject survey; this page stays inside Georgia. The clinical layer on top of scope is our injectables safety and compliance guide; the rest of our state work is on the Georgia med spa compliance hub.

Injecting Botox Is the Practice of Medicine in Georgia

Everything downstream follows from one classification. Botulinum toxin — Botox, Dysport, Xeomin, Jeuveau, Daxxify — and every hyaluronic acid, poly-L-lactic acid and calcium hydroxylapatite filler is a prescription product. Ordering one for a specific person, choosing the dose and the anatomic target, and putting it under their skin is diagnosis and treatment. In Georgia that is the practice of medicine.

What the statute says

O.C.G.A. § 43-34-21 defines practising medicine to include holding oneself out as engaged in the diagnosis or treatment of disease, defect or injury, and the suggestion, recommendation or prescribing of any form of treatment for the palliation, relief or cure of any physical or functional ailment, with the intention of receiving a fee. A cosmetic purpose does not move an act out of that definition. Compare O.C.G.A. § 43-34-242, where the legislature declared non-ablative cosmetic laser services expressly not to be the practice of medicine. Georgia knows how to carve an aesthetic service out of medicine. It has not done it for the needle.

O.C.G.A. § 43-34-22 makes doing any of that without a licence unlicensed practice, and O.C.G.A. § 43-34-42 supplies the penalty: a felony, punishable by a fine of $1,000.00 per violation, imprisonment of two to five years, or both. Note the section number: Georgia recodified the Medical Practice Act effective July 1, 2009, and the old penalty provision — § 43-34-26, still quoted in a great many compliance binders and blog posts — was redesignated.

Two boards, three rulebooks

No single agency owns the answer. The Georgia Composite Medical Board (GCMB) licenses physicians and PAs, approves PA job descriptions, receives nurse protocol agreements, and disciplines the delegating physician when supervision is nominal. The Georgia Board of Nursing, under the Secretary of State's Professional Licensing Boards Division, licenses RNs, LPNs and APRNs and publishes the position statements that decide what a nurse may do with a syringe. Estheticians answer to the Board of Cosmetology and Barbers. Enforcement files usually involve all three.

What Georgia does not have

Three absences shape the compliance picture, and each gets papered over with an invented rule:

• No med spa facility licence. Georgia does not license "med spas" as a category. Compliance attaches to individual credentials and the delegation documents connecting them — which is how a practice looks immaculate from the street while being non-compliant in its staffing for years.
• No office-based cosmetic procedure rule. GCMB Chapter 360-32 is titled "Nurse Protocol Agreements Pursuant to O.C.G.A. Section 43-34-25" — the nurse protocol chapter, not a cosmetic procedures chapter.
• No statutory phrase "good faith examination" for injectables. The pre-treatment examination requirement is real, but built from the Board of Nursing's position statement and the Medical Board's unprofessional conduct and telemedicine rules, as the examination section below shows.

How Delegation Works in Georgia — and the Provider Table

Georgia runs cosmetic injections through a chain with three links: a physician's licence at the top, a delegation document in the middle, a patient-specific order at the point of care. Break any link and the treatment is unlawful even when a perfectly qualified person holds the syringe.

Two delegation statutes, and only one carries a prescription pad

O.C.G.A. § 43-34-23 is the general delegation section: a physician may delegate to a PA in accordance with a job description, or to an APRN in accordance with a nurse protocol, the authority to order dangerous drugs, treatments and diagnostic studies. Its most important sentence is the last one — a PA or nurse performing an act authorised under it, in conformity with it, is not practising medicine. That is the mechanism by which a non-physician lawfully performs a medical act here, and it names only two categories of delegate.

O.C.G.A. § 43-34-25 is the section an injectables practice actually lives under, because it carries prescription drug order authority. It authorises a delegating physician to enter a written nurse protocol agreement with an APRN and to delegate the authority to issue prescription drug orders within it. An APRN under a § 43-34-23 protocol without prescriptive authority may perform delegated acts but cannot order the neurotoxin — which, in this business, is everything. Know which section your protocol was written under.

The one-screen provider table

Georgia asks the same question in every investigation: whose order authorised this treatment for this patient, and what evaluation preceded it? Three roles answer in their own name, one answers by pointing at someone else's order, and nobody else can answer at all.

Physicians (MD and DO): Full Authority, Real Duties

Verdict: yes, on their own authority. A physician with an active Georgia licence may evaluate, select product and dose, write the order and inject. The physician is also the source of everyone else's authority in the building, which is why the delegating role carries obligations that get overlooked when the physician is a signature rather than a working clinician.

Georgia licensure is not portable

The delegating physician must hold an active Georgia licence. A physician licensed only in Florida, Alabama, Tennessee or the Carolinas cannot delegate to a Georgia APRN, supervise a Georgia PA, or stand behind a Georgia RN's injection, because delegating a medical act performed on a patient in Georgia is itself practising medicine in Georgia — § 43-34-22 territory, with § 43-34-42 attached. Georgia's cosmetic laser article does let a consulting physician practise outside the state if within 50 miles of the facility — an allowance for laser services that does not extend to neurotoxin or filler.

What the delegating physician signs up for

Under § 43-34-25 and GCMB Chapter 360-32, delegating to an APRN carries concrete, auditable duties:

• Availability for immediate consultation. If they cannot be available, they must designate another physician of the same scope in writing, attached to the protocol, with that physician's name, licence number and signature.
• A predetermined plan for emergency services inside the protocol agreement — where vascular occlusion and anaphylaxis response belong, not in an unsigned binder.
• Record review on a schedule. Rule 360-32-.02 sets the minimum: 100% of records where a controlled substance prescription was issued, reviewed and signed at least quarterly; 100% of records involving an adverse outcome, within 30 days of discovery; and at least 10% of all other patient records annually. Neurotoxins and fillers are not controlled substances, so aesthetic practices live in the 10%-annually bucket — until something goes wrong, when the 30-day review becomes mandatory and its absence conspicuous.
• Training oversight. Under the Board's 2026 amendments, delegating physicians must ensure their APRNs receive annual pharmacology training and the relevant biennial continuing education. Failing to do so before delegating is itself disciplinable.

How many people one physician may carry

The old limit was four APRNs; House Bill 1046, signed in 2024, changed it to the combined equivalent of eight APRN nurse protocol agreements and PA job descriptions at any one time, with exceptions for settings such as hospitals, health departments and free clinics — none of which describes a med spa. APRNs and PAs count against the same eight. Older published copies of the Board's PA rules still show the pre-amendment four-PA limit, so read the current rule text before signing the fifth agreement. The structural questions above all this — who the medical director is, what they are paid, what they are responsible for — are in our Georgia medical director requirements guide.

APRNs and Nurse Practitioners: The Protocol Is the Scope

Verdict: yes — inside a current nurse protocol agreement, and never outside one. An APRN with prescriptive authority under a § 43-34-25 protocol may perform the evaluation, issue the prescription drug order, inject, and order the treatment an RN then administers. That is the whole injectables job. What Georgia does not offer is any way to do it alone.

Georgia has no independent APRN practice

Georgia is a restricted-practice state and has stayed one. There is no hours threshold, transition-to-practice period or grandfather clause that releases an APRN from the delegating physician relationship. An APRN running an injectables practice without a current, executed protocol is practising outside scope, and the acts performed lose the § 43-34-23 protection that keeps delegated acts from being the practice of medicine — which removes the legal basis for the treatment.

What the protocol must contain

The protocol is the operative document and Georgia is specific about it. It must be written, dated and signed by the APRN, the delegating physician and any designated physicians; carry a current review date and be available on request; specify the parameters under which delegated medical acts may be performed, including the diagnostic studies that may be ordered and the circumstances under which prescription drug orders may be issued; and contain the predetermined plan for emergency services. It is filed with the Board under Rule 360-32-.03. A 2024 change is widely misread: a protocol submitted on the Board's substantially similar form is deemed valid upon submission, but the Board still reviews it and may rescind approval. Two APRNs with identical certifications can therefore hold different authority: if the protocol does not authorise prescription drug orders for the category in question, that APRN cannot order the neurotoxin, though they may still inject one someone else ordered. Verify the document, not the initials on the badge — our Georgia nurse protocol agreement deep dive works through a compliant document clause by clause.

What the 2026 position statements did and did not do

On May 7, 2026, the GCMB issued a position statement covering the delegating physician/APRN relationship, the supervising physician/PA relationship, and IV hydration and therapy. It requires that supervisory relationships reflect genuine clinical oversight and targets compensated arrangements — including third-party matching services that collect a fee for assigning and paying a delegating physician — where meaningful collaboration is absent. On the IV side it requires a valid individualised order and a completed history and physical performed by a physician, an APRN with an active prescriptive protocol, or a PA with job description authority, and prohibits standing orders. That statement addresses IV therapy and supervisory structure, not neurotoxin — but it mirrors the Board of Nursing's cosmetic statement almost clause for clause. It also has a second half most summaries omit: after significant pushback the Board issued a public notice on May 26, 2026 calling it preliminary guidance, and on June 5, 2026 clarified that it was not creating new law, not terminating active protocols, and not advising practices to close. If someone tells you Georgia banned APRN-owned med spas in 2026, they read the May statement and stopped reading.

Physician Assistants: The Job Description Is the Scope

Verdict: yes — to the extent the Board-approved job description says so. A Georgia PA may evaluate, prescribe and inject where those acts fall within the job description approved for that PA and that supervising physician.

No job description, no medical acts

Under O.C.G.A. § 43-34-103, a licensed PA may perform no medical act except as approved for utilisation by a physician in a job description. Board Rule 360-5-.05 puts it flatly: nobody practises as a PA without a licence or temporary permit, Board approval of a supervising physician, and Board approval of the job description. A job description describing primary care and silent on cosmetic injectables does not cover the PA's aesthetic work, however well trained the PA is.

What an injectables job description should say

One that survives scrutiny names the procedures (neuromodulator and dermal filler injection by product class and anatomic region), the prescribing authority delegated and its limits, the evaluation the PA may perform, the circumstances requiring consultation, and the emergency protocol including hyaluronidase use. Vagueness is not protective here; it is the finding.

Ratios, supervision and one stale rule

The supervising physician need not be on site for each encounter but must be genuinely available and meet the Board's review obligations — the May 2026 "genuine clinical oversight" language reaches the PA relationship as directly as the APRN one. On ratios, the 2024 combined equivalent of eight covers PA job descriptions and APRN protocols together. Published copies of Rule 360-5-.05 predating the amendments still read "a physician may serve as primary supervising physician to only four physician assistants," and still say a PA may not sign death certificates — a tell that you are reading an outdated compilation. A PA also cannot become the delegation source for a med spa: a PA's order can authorise an RN's administration where the job description carries prescriptive authority, but it cannot replace the physician in the oversight structure.

Registered Nurses: They May Administer, Not Assess

Verdict: yes to the injection, no to everything around it. This row decides most Georgia med spa staffing models, and Georgia's answer is unusually well documented for a state with no cosmetic rule chapter.

What the Georgia Board of Nursing actually said

The Board of Nursing's position statement on Cosmetic/Aesthetic Procedures, dated April 1, 2024, is the controlling guidance and it is refreshingly direct. It defines cosmetic and aesthetic procedures as neuromodulator and dermal filler injections, naming Botox, Restylane and collagen, and states that performing them is within the scope of an RN, not an LPN, if authorised by a valid individualised order prescribed by a physician, nurse practitioner or physician assistant with prescriptive authority. Then it puts the burden on the nurse: the nurse must ensure there is a valid individualised order from an authorised prescriber and a client history and physical performed by the prescriber for procedure appropriateness, before administering anything. And it closes the door the industry keeps propping open — standing orders are not an appropriate substitute for the individualised order and the history and physical.

Why "the RN may not assess" is a real limit

Georgia's nursing statute, O.C.G.A. § 43-26-3, describes registered professional nursing as assessing health status and administering medications and treatments as prescribed by an authorised prescriber. Nursing assessment is not the medical evaluation that decides whether someone is a candidate for a prescription neurotoxin, at what dose, in which muscles. What the RN cannot be is the evaluation that justifies the prescription. From the treatment chair those two things look identical, which is exactly why they get conflated in the chart and then separated by an investigator.

What a valid patient-specific order contains

Georgia publishes no order template. The practical minimum:

• The patient's name and the date of the evaluation supporting it
• The prescriber's name, credential and signature — whoever performed the history and physical
• The product by name (Botox, Dysport, Xeomin, Jeuveau, Daxxify, or the specific filler), not a drug class
• Dose in units or volume, the anatomic sites authorised, and the limits: maximum units, areas excluded, parameters for declining to treat
• What the RN does if the presentation differs from the plan, and who to call

"Botox per protocol, PRN" for a patient the prescriber never evaluated is the fact pattern in the Board of Nursing's consent orders. It is individualised in neither the patient nor the treatment.

Standing orders and the solo-RN problem

Standing orders have a legitimate operational role — emergency response, anaphylaxis, hyaluronidase availability, infection control, the parameters within which an individualised order is executed. What they cannot do is manufacture the missing evaluation: the Board of Nursing said so for cosmetic procedures in 2024, and the Medical Board said the same about IV therapy in 2026. That 2026 statement added the structural point — diagnosing and developing treatment plans fall outside RN and LPN scope, and a nurse cannot be the sole healthcare professional treating the patient. A practice built around a solo RN and a distant prescriber's signature has that shape whatever is on the menu.

LPNs, Medical Assistants, Estheticians and Unlicensed Staff

Four roles, four flat answers — and four sets of work these staff can do lawfully and profitably instead.

Licensed practical nurse — no

Verdict: no. The Board of Nursing's 2024 cosmetic position statement draws the RN/LPN line in a single sentence: performing ordered cosmetic and aesthetic procedures is within the scope of an RN, not an LPN. Georgia's practical nursing statute, O.C.G.A. § 43-26-32, describes practice under the supervision of a physician, dentist, podiatrist or registered nurse, and injecting a prescription neurotoxin is not among the tasks the Board recognises. An LPN can take intake histories for the prescriber's review, prepare the room and patient, document, monitor and provide post-treatment care — but cannot hold the syringe.

Medical assistant — never

Verdict: never. Medical assistants are unlicensed in Georgia, and no certification changes the analysis. Two barriers apply at once: § 43-34-23 permits delegation only to PAs under a job description and nurses under a protocol, and an MA is neither; and the Board of Nursing's position on unlicensed assistive personnel is that nurses may not delegate activities requiring nursing licensure to unlicensed individuals absent statutory authority, which the Nurse Practice Act does not provide. An MA injecting botulinum toxin in Georgia is practising medicine without a licence under § 43-34-22, a felony under § 43-34-42 — and the exposure is not the MA's alone. The physician whose name is on the wall, the APRN or PA who wrote orders into that workflow, and the RN who trained the MA sit inside the same file.

Esthetician and cosmetologist — never

Verdict: never, for injections of any kind. Georgia's cosmetology statute, O.C.G.A. § 43-10-1, defines esthetics as massaging the face, neck, décolletage or arms; shaping eyebrows; eyelash and eyebrow services; and waxing, cleansing, stimulating or beautifying the skin with the hands, an apparatus or a cosmetic preparation — and states that esthetics does not include the diagnosis, treatment or therapy of any dermatological condition, medical aesthetics, or the use of lasers. A licence bounded by "cosmetic preparation" does not reach a prescription drug delivered through a needle, and the answer does not change if the esthetician owns the business.

Unlicensed staff, and what everyone here can do instead

Verdict: never. Georgia has no unlicensed-delegatee route for injections, and weekend certification is training, not licensure. When the GCMB began unannounced inspections of med spas and IV clinics in 2026, unlicensed workers providing medical services was among the first findings reported. What these roles can lawfully do is most of the business:

• Consultations that are not evaluations. Explaining products, pricing, downtime and aftercare is not diagnosis. Recommending a treatment plan for a specific person's face is.
• Esthetics under the cosmetology licence — facials, waxing, superficial exfoliation and skin care retail, in a facility with the licensure the setting requires.
• Cosmetic laser services under a laser practitioner licence. Georgia has a statutory path at O.C.G.A. §§ 43-34-240 through 43-34-253: assistant and senior cosmetic laser practitioners. Assistants must have patients examined by the consulting physician, or a PA or ARNP who is a licensed laser practitioner, before service, with laser hair removal and pulsed light excepted; in 2026 the Board expanded the definition to reach energy-based devices including ultrasound, cryolipolysis, microwave and radiofrequency. A real career track that still never reaches a syringe — our Georgia laser safety guide covers it.
• Everything around the treatment — scheduling, intake, photography, inventory, room turnover, and follow-up that gives no clinical advice.

Dentists, Podiatrists and Optometrists: The Site-Limited Answers

These three licences generate steady Georgia search volume, and all three answers turn on anatomy rather than skill.

Dentists

Verdict: yes, within dentistry — and personally. Board of Dentistry Rule 150-14-.04, "Administration of Injectable Pharmacologics," defines an injectable pharmacologic to include neurotoxins and fillers by name — hyaluronic acid such as Restylane, collagen, and Botulinum Toxin Type A such as Botox. A Georgia dentist may administer them for functional or cosmetic enhancement of the gums, cheeks, jaws, lips, oral cavity and associated tissues in connection with dental treatment, after a Board-approved postdoctoral course of at least 21 hours, filing the completion certificate within 30 days; graduates of an ADA-accredited oral and maxillofacial surgery programme are exempt from the course. Two limits matter more than the permission: the scope is tied to dentistry and the orofacial region the rule describes, and the dentist must personally perform every step — evaluation, prescribing and administration — delegating none of them. That is why dentists wanting a full cosmetic menu build it with a physician or APRN instead.

Podiatrists

Verdict: within the foot and leg only. Georgia podiatric practice is defined by site: O.C.G.A. § 43-35-3 frames podiatric medicine around the human foot and leg. A therapeutic botulinum toxin injection for a foot condition can sit inside that boundary; a glabellar treatment does not, and injection training does not move it there. Georgia has issued no guidance authorising podiatrists to perform facial cosmetic injections, and that absence is not an ambiguity to exploit.

Optometrists

Verdict: expressly excluded. O.C.G.A. § 43-30-1 permits certified Georgia optometrists to administer pharmaceutical agents for conditions of the eye and adnexa oculi by injection, then lists the carve-outs: sub-Tenon, retrobulbar, peribulbar, facial nerve block, subconjunctival anaesthetic, intravenous, intramuscular, intraorbital nerve block and intraocular injections — and by name dermal filler and botulinum toxin injections. It is one of the few places in American scope-of-practice law where a legislature named Botox and fillers and said no.

The Patient Examination Before Any Georgia Injection

Most states with a mature aesthetic sector have a rule using the phrase "good faith examination." Georgia does not, for injectables, and pretending otherwise has produced more bad compliance advice here than any other single error. The requirement is real. Here is where each piece comes from.

Who must perform it

A physician, an APRN with prescriptive authority under a current protocol, or a PA with the relevant job description authority — the three the Board of Nursing named in requiring a history and physical performed by the prescriber, and the same three the Medical Board named in 2026. An RN cannot perform it.

What it must include

Georgia publishes no checklist for cosmetic injections, so the content standard comes from GCMB Rule 360-3-.02, which makes it unprofessional conduct to fail to use such means as history, physical examination, laboratory or radiographic studies, where applicable, to diagnose a medical problem, and to fail to maintain records documenting the course of evaluation, treatment and response. Applied to a neurotoxin consultation, a defensible evaluation covers:

• History, current medications and prior aesthetic treatments, including previous neurotoxin brand, dose and response
• Contraindication screening: hypersensitivity, infection at the site, neuromuscular disorders such as myasthenia gravis, pregnancy and breastfeeding, aminoglycoside and other interacting therapy
• For fillers, an anatomic and vascular risk assessment of the region, prior filler in the area, and any history of vascular events
• Focused examination of the treatment area — muscle activity, asymmetry, skin quality, site condition
• A documented plan with product, dose and sites, plus informed consent covering material risks
• The prescriber's signed order in the chart, before the injection

Does telemedicine satisfy it?

Sometimes, on Georgia's terms, and never through a questionnaire. GCMB Rule 360-3-.07, "Practice Through Electronic or Other Such Means," authorises care by electronic means where a Georgia-licensed physician, PA or APRN has personally seen and examined the patient; or acts at the request of a Georgia-licensed provider who has; or can examine the patient using technology and peripherals equal or superior to an in-person examination. The provider must document the evaluation and make diligent efforts to have the patient seen in person by a Georgia-licensed provider at least annually, and Rule 360-3-.02 separately treats prescribing based solely on an electronic consultation as unprofessional conduct. Whether video can support filler in a high-risk region is a question Georgia has not answered; the standard is technology equal or superior to an in-person examination for the assessment being made, which a facial vascular assessment strains harder than a glabellar follow-up does.

How often must it be repeated?

Here Georgia is genuinely unsettled, and it is better to say so than to invent an interval. No Georgia statute or board rule sets an expiry for a cosmetic pre-treatment evaluation; the nearest anchors are the telemedicine rule's annual in-person expectation and the requirement that every treatment rest on a valid individualised order. Defensible Georgia programmes re-evaluate at least annually, and always when the product, dose, region or clinical picture changes, when a complication appears, when the patient reports a new diagnosis, medication or pregnancy, and when a different prescriber takes over. Setting that interval in your protocol and meeting it beats arguing about what Georgia never specified.

Who May Own a Georgia Injectables Practice — and What Is Unsettled

Ownership is a separate question from scope, and the murkier of the two in Georgia. Nothing here changes who may inject; it changes who may hold the entity and take the profit.

What is settled

Georgia has no single corporate practice of medicine statute of the kind California has. What it has is the professional corporation framework in Title 14 of the Code: shareholders of a professional corporation organised to practise a profession must be licensed in that profession and actively engaged in it, and only licensed officers, employees and agents may render the professional service. Medicine is an enumerated profession, and that framework plus the Board's authority over physicians who lend their licences does most of the work a formal doctrine would do elsewhere.

What is not settled — and what to do about it

Whether and how an APRN or PA may own a Georgia business delivering medical aesthetic services is contested, and competent Georgia health lawyers disagree in print. The GCMB's May 2026 statement pushed hard on APP-owned practices and the supervision arrangements supporting them; its follow-up notices then called it preliminary guidance aimed at compensated arrangements without meaningful collaboration. The Board has not resolved the question by rule, so any confident claim in either direction states a position, not the law. Structure so the answer does not decide your survival: a documented physician relationship, compensation not contingent on the volume of delegated treatments, a delegating physician who can demonstrate oversight through completed record reviews, and no third-party arrangement whose only product is a signature. Our Georgia med spa ownership guide works through the entity structures and MSO questions in detail.

Product Sourcing and Handling: Prescriber of Record to Lot Number

Scope answers who may inject. Sourcing answers what they are injecting and whose licence bought it — and in 2026 this is where a compliant-looking practice most often has a real problem.

Whose name is on the account

Neurotoxins and fillers are prescription products, bought on a licensed prescriber's authority, held for that prescriber's patients, and reconciled against orders. In Georgia that prescriber is a physician, an APRN whose protocol carries prescriptive authority, or a PA whose job description carries it. When the injector, the prescriber on the order and the licence on the distributor account are three different people, the question of who authorised the drug becomes unanswerable at exactly the moment it is asked.

Ordering, storage, reconstitution and lot tracking

Buy through authorised US distribution — the manufacturer or an authorised wholesaler, on the practice's prescriber account, with invoices retained. Botulinum toxin products come as vacuum-dried or lyophilised powder with product-specific refrigerated storage requirements, reconstituted with preservative-free 0.9% sodium chloride per labelling and used within the stated post-reconstitution window; fillers carry their own storage and single-patient-use requirements. Log refrigerator temperatures daily, because an undocumented excursion is indistinguishable from an unnoticed one. Reconstitution sits inside the licensed scope of whoever performs it. The GCMB's 2026 inspection findings also named unlawful compounding — reconstituting per labelling is not compounding, but combining products, diluting beyond labelling or preparing multi-patient syringes moves toward territory Georgia's pharmacy law governs. Record product, manufacturer, lot number, expiry and, for reconstituted toxin, the reconstitution time and diluent volume in every note: lot capture is what makes a recall actionable after an adverse event cluster.

Foreign and grey-market product

This is not theoretical. Between November 2023 and April 2024, seventeen people across nine states developed symptoms including blurred vision, ptosis, dysphagia and difficulty breathing after injections with counterfeit product or product from unverified sources; thirteen were hospitalised and six were treated with botulism antitoxin. Some had been injected by unlicensed people in non-healthcare settings, others by licensed injectors who bought outside authorised distribution. In November 2025 the FDA issued warning letters to eighteen website operators illegally marketing unapproved and misbranded botulinum toxin products, nine of them based in Asia. Such product may be unapproved, misbranded, adulterated, contaminated or improperly stored, and the price difference is a rounding error against one botulism admission.

Charting That Survives a Complaint

Georgia investigations run on documents. When a board opens a file nobody watches the injection — they read what you wrote about it, months later, in whatever order the records happen to sit.

The delegation file

Keep one place, current, that a stranger could audit in ten minutes: the delegating physician's active Georgia licence; each APRN's executed nurse protocol agreement, signed and dated by all parties, carrying its current review date, with any written designation of an alternate physician attached; each PA's Board-approved job description and supervising physician approval; completed record reviews with dates and signatures, including the 10% annual sample and any 30-day adverse outcome reviews; training records for every injector and procedure; and the emergency plan the protocol requires. The most common Georgia finding is not a missing document — it is one that exists but was never reviewed, dated or updated after the physician of record changed.

The injection note, line by line

• Date, the name and credential of whoever performed the evaluation, and the individualised order it was performed under with the prescriber's signature
• Consent: what was disclosed and discussed, patient signature and date, and re-consent when the plan changes
• Product, manufacturer, lot number, expiry, dilution and total units or volume — per anatomic site, not as a single sum
• Technique notes relevant to risk: depth, plane, cannula versus needle for filler
• Immediate response, any event during treatment, the instructions given, and photographs where your protocol calls for them
• Any deviation from the order — what changed, why, who authorised it, when

What investigators ask for first

The opening request is predictable: the protocol agreement or job description, the delegating physician's record reviews, the complaining patient's chart including the pre-treatment evaluation and the order, the injector's training file, and the adverse event log. The 2026 inspection wave reported failure to track adverse events as a distinct finding — not the events, the tracking. If you have no log because you have had no events, create it anyway: an empty log with a start date is evidence and a shrug is not. The Georgia med spa compliance checklist lists the full document set to assemble before anyone asks.

Complications, Hyaluronidase and Who Must Be Reachable

Scope rules exist because these products cause harm when the wrong person injects them or the right person is unprepared. Georgia's delegation framework has a readiness requirement built into it that most practices have never noticed.

The emergency plan is a protocol requirement

Every nurse protocol agreement under § 43-34-25 must contain a predetermined plan for emergency services. It should name the events covered — vascular occlusion, impending skin necrosis, visual changes, anaphylaxis, vasovagal syncope, injection site infection — state what the on-site clinician does first, who is called and how fast, and what triggers transfer and to where. Naming the receiving facility in advance is the difference between a plan and a paragraph.

Hyaluronidase access

Any Georgia practice injecting hyaluronic acid filler should be able to reach hyaluronidase immediately, in adequate quantity, in date, with a prescriber's authorisation for emergency use already in place. Hyaluronidase is itself a prescription drug, so the same delegation logic applies: an RN giving it in an emergency is administering on an order, so that authorisation and its parameters must exist in the protocol in advance. A vial in a drawer with no order behind it, and nobody credentialed to authorise its use at 6pm on a Saturday, is not access — and published occlusion protocols use far more than a single vial across repeated dosing.

Vascular occlusion, and who must be reachable

The recognition and management sequence — pain and blanching out of proportion, delayed capillary refill, livedo pattern, the flooding technique, repeat dosing, and the visual-change emergency that goes straight to ophthalmology — is a clinical topic in its own right: our vascular occlusion guide has the full protocol. The Georgia scope point belongs here: an RN can execute an emergency protocol but cannot diagnose the occlusion, decide to deviate, or authorise a new drug. Somebody with prescriptive authority has to be genuinely reachable while patients are being injected — which is what "available for immediate consultation" means in § 43-34-25. Georgia sets no response-time standard for injectables, so put it in your schedule: for every hour you inject, name the prescriber on call and record the designation in the protocol. A physician in surgery during your Saturday clinic is not available for immediate consultation, and who was covering is the first thing an investigator reconstructs.

Enforcement: What Georgia Actually Charges — and the Myths Behind It

Georgia's enforcement posture changed materially in 2026, and the fact patterns are consistent enough to learn from directly.

The three files an investigation opens

An unlicensed person injecting is charged as unlicensed practice under § 43-34-22, a felony under § 43-34-42, with the GCMB able to refer criminally. The delegating physician is the second file, always, and the questions are documentary: was the protocol executed and current, were record reviews done at the required frequency, was the physician available for immediate consultation with an alternate designated in writing, and did the physician ensure the required training. A physician who lent a signature and never reviewed a chart is exposed on all four. The third file is the Board of Nursing's: the RN who injected without a valid individualised order, treated a patient the prescriber never evaluated, modified a plan unilaterally, or delegated to unlicensed staff.

The 2026 inspection wave

Following news coverage of oversight gaps in Georgia's wellness sector, the GCMB began unannounced site visits at med spas, IV hydration clinics and similar practices, urban and rural. Reported findings included medical services delivered by unlicensed workers, unlawful compounding, staff practising outside their scope of training, clinics without physician oversight, treatments given without the required examinations, operators not tracking adverse events, and chiropractors offering weight loss and testosterone treatments Georgia does not permit them to prescribe or inject. The Board has signalled it will enforce existing law and seek legislation adding registration requirements. The era in which nobody came to look at a Georgia med spa is over, and the visit is unannounced.

Six myths, corrected

• "GCMB Rule 360-32 requires a good faith exam before cosmetic injections." No. Chapter 360-32 is the nurse protocol chapter under § 43-34-25. The examination requirement comes from the Board of Nursing's 2024 position statement and GCMB Rules 360-3-.02 and 360-3-.07.
• "An MA injecting Botox violates § 43-34-26." Outdated: that section was redesignated in 2009. Unlicensed practice is § 43-34-22, the felony penalty § 43-34-42.
• "A standing order from our medical director covers new patients." No. Both boards have said in writing that standing orders are not a substitute for the individualised order and the prescriber's history and physical.
• "An experienced APRN can practise independently in Georgia." No. There is no independence threshold here; without a current nurse protocol agreement, the authority to prescribe and perform delegated medical acts does not exist.
• "Our delegating physician is licensed next door, which is close enough." No. The 50-mile consulting physician allowance belongs to the laser article; delegating physicians for injectables need an active Georgia licence.
• "A certified aesthetic injector course qualifies our esthetician." No. Training is not licensure, and § 43-10-1 excludes medical aesthetics from esthetics practice.

If you are building or auditing a Georgia injectables practice, start with the delegation file and the order, because that is where Georgia starts. Our state work is indexed on the Georgia hub, and the templates that implement it are at MedSpa Standards.

Disclaimer: This article is for educational purposes only and does not constitute legal advice. Georgia scope-of-practice and supervision rules involve complex statutory and regulatory considerations specific to your facility, providers, and procedures. Board rules and position statements change, and several questions covered here remain unsettled in Georgia. Consult with a Georgia healthcare attorney before establishing your provider structure, nurse protocol agreement, or written protocols.